We compared estimates for base excess of extracellular fluid (BE ecf ; mmol/L) obtained in five clinically used blood gas analyzers: AVL Compact 2 (Roche Diagnostics, Mannheim, Germany), Ciba-Corning 860 (Bayer Diagnostics, Fernwald, Germany), IL 1620 (Instrumentation Laboratories, Lexington, MA), Stat Profile Ultra (Nova Biomedical, Waltham, MA), and ABL 510 (Radiometer, Copenhagen, Denmark). A total of 134 measurements per analyzer were obtained in arterial and venous blood samples from 10 patients undergoing cardiac surgery and 65 measurements per analyzer in venous blood samples from 2 healthy volunteers. The blood samples were equilibrated in a tonometer with gases of known composition (37°C). Additional theoretical studies were performed to evaluate the relationship between pH and calculated BE ecf value (with varied Pco 2 ) using the formulas of the various analyzers. The standard deviations of repeated measurements were 0.24 mmol/L for ABL 510 and approximately 0.45 mmol/L for the other 4 analyzers. The maximal systematic difference between the average of all measurements of each analyzer was 3.7 mmol/L; this was primarily attributable to differences in measuring pH, and, to a lesser extent, to differences in calculation and determination of Pco 2 . Comparison of the results from samples with different oxygen saturation showed that the relative alkalinity of deoxygenated hemoglobin (Haldane effect) can also influence the determinations of BE ecf . (Anesth Analg 2002;94:1141-8) 
V alues for base excess are used widely to evaluate the nonrespiratory component of acid-base balance in patients. The determinations of base excess in the extracellular fluid (BE ecf ) are usually performed by using instruments, so-called "blood gas analyzers," that simultaneously measure the partial pressures of oxygen (Po 2 ) and carbon dioxide (Pco 2 ), as well as of pH in a blood sample. Calculated estimates for BE ecf are derived by applying these measured values to an algorithm that is unique for the particular analyzer. Thus, these estimates for BE ecf may vary depending on which analyzer is used. This variability is compounded by the inherent error involved in measurements of Po 2 , Pco 2 , and pH.
Errors in the estimates for BE ecf can lead to misdiagnosis and potentially harmful treatment strategies, or to an underestimation of the severity of the metabolic derangement, which can result in inadequate or delayed treatment. This can be potentially life threatening because of impairments on the biochemical, cellular, and tissue levels, leading to failure of vital organs. Moreover, both acidosis and alkalosis can diminish the effectiveness of drug therapy and other treatment maneuvers, including controlled ventilation. Thus, it is important that the clinician appreciate the limitations of the clinically available estimates for BE ecf , and to what extent they can be relied on as a basis for treatment.
The current study was conducted to compare, in a systematic manner, the ability of five commercially available, clinically used blood gas analyzers to provide estimates of BE ecf from measurements of Pco 2 , Po 2 , and pH in samples of blood. Arterial, venous, and tonometered blood samples from patients and healthy volunteers were used. Mathematical correction for the effect of oxygen saturation (So 2 ) on estimates of base excess of whole blood (BE bl ), the so-called "Haldane effect," has been suggested (1, 2) . We assessed the advantage of this correction in the estimates of BE ecf .
Methods
The study was comprised of five modern automatic blood gas analyzers: the AVL Compact 2 (Roche Diagnostics, Mannheim, Germany), the Ciba-Corning 860 (Bayer Diagnostics, Fernwald, Germany), the IL 1620 (Instrumentation Laboratories, Lexington, MA), the Stat Profile Ultra (Nova Biomedical, Waltham, MA), and the ABL 510 (Radiometer, Copenhagen, Denmark). The instruments were standard models for both point-of-care and laboratory use and they were provided, put into operation, and maintained by the respective manufacturers or their authorized contractors. The same standards for test performance are used for the point-of-care and laboratory applications of these instruments, as indicated by the manufacturer. Two-point calibrations were performed just before the test series each day (manually started on each of the analyzers simultaneously) followed by intervals that were programmed in the devices.
The Radiometer ABL 510 uses a relatively complex algebraic simulation of the acid-base nomogram introduced by Siggaard-Andersen (3) to calculate BE ecf . On the basis of the recommendation by the International Federation of Clinical Chemistry (IFCC) (4), the other analyzers have simplified these formulas:
The respective constants are presented in Table 1 . A correction was made for the Haldane effect, i.e., incomplete oxygen saturation, in all estimates of BE ecf by using the following formulas (2, 5, 6) :
with
Only the Radiometer ABL 510 (measurement) and Nova Stat Profile Ultra (determination via hematocrit) analyzers provide the concentration of hemoglobin (cHb, [g/dL]), which is a value required in Equation 3.
Theoretical studies were performed to assess differences in the calculated BE ecf values obtained using the equations used by the various blood gas analyzers. A plot of the relationship between the pH values and the calculated values for BE ecf was generated at Pco 2 values approximating hypocapnia, normocapnia, and moderate and severe hypercapnia.
Experimental studies were performed in which a value for BE ecf was obtained for the same blood sample using each of the five blood gas analyzers in sequence. Arterial and central venous blood samples were obtained from 10 patients undergoing cardiac surgery (63 Ϯ 12 yr of age, elective operations under clinically stable conditions). Seven determinations of BE ecf were obtained for each of the 20 blood samples in each analyzer. This number of determinations was chosen on the basis of statistical, cost, and time considerations.
In addition, we obtained venous blood samples from two healthy volunteers and analyzed them for gases and pH with and without equilibration with specific gas mixtures using a Tonometer (IL 237; Instrumentation Laboratories). The samples of venous blood were analyzed for BE ecf eight times before, and three times after, tonometry. A comparison of the preand post-tonometry values for BE ecf provided insight into the effect of time, e.g., storage duration, on the values for BE ecf . The samples were stored in ice water for 6.5 h between the BE ecf determinations. The venous blood samples were equilibrated in the tonometer with 4 gas mixtures: 5% CO 2 , 95% O 2 , 0% N 2 ; 5% CO 2 , 20% O 2 , 75% N 2 ; 10% CO 2 , 0% O 2 , 90% N 2 ; 8% CO 2 , 92% O 2 , 0% N 2 . These gas mixtures were standard mixtures provided by commercial suppliers of medical gases (AGA Gas, Neunkirchen, Germany), which encompassed a wide range of values for Pco 2 and Po 2 .
We also analyzed in each instrument an arterial blood sample from one of the volunteers five times before and five times after the measurements on tonometered blood to evaluate the differences between arterial and venous samples drawn simultaneously (50 measurements). Thus, the total number of measurements was: 700 (during operations) ϩ 2 · 55 (healthy, venous) ϩ 2 · 120 (healthy, tonometered) ϩ 50 (healthy, arterial) ϭ 1100.
Written informed consent was obtained from all patients and volunteers in accordance with the regulations of the local ethics committees. In the surgical patients, the blood samples were obtained from arterial and central venous catheters that had been inserted for routine monitoring purposes. Before withdrawing the samples for analysis, 5 mL of blood was withdrawn into a separate syringe to avoid contamination by stale blood or drug solutions that may have been in the catheters. Direct punctures of the cubital vein and femoral artery were used to obtain blood samples from the volunteers. Ten-milliliter polypropylene syringes were used for blood sampling in the study (B. Braun Melsungen AG, Melsungen, Germany). The untreated arterial and venous samples were introduced into the blood gas analyzers directly from these syringes. A special procedure, using 2-mL syringes of the same type, was used to transfer blood from the tonometer to the analyzers. The walls of all syringes used in this study were moistened and the dead space was filled with sodium heparin solution (5000 IU/mL, Liquemin N 25,000; Hoffmann-La Roche AG, Grenzach-Wyhlen, Germany) to prevent clotting of blood and the introduction of air bubbles into the syringe. All blood samples were put in ice water immediately and transported to the laboratory within 10 min. The storage time on ice ranged between 1 and 4 h for the blood samples from the patients and between 4 and 7 h for the blood samples from the healthy volunteers. The syringes were removed from the ice water immediately before analysis, rolled between the palms for 5 s, and turned three times upside-down to ensure adequate mixing. Then, the content of the cone of the syringe was expelled into a compress. The order in which each blood sample was analyzed by the different instruments was varied randomly to exclude experimental bias.
Data acquisition was performed automatically by using two standard personal computer systems directly connected to the blood gas analyzers. Statistical analysis included calculation of means and standard deviations and the use of the Student's t-test, MannWhitney U-test, and Wilcoxon's matched-pairs, signed rank test to uncover statistically significant differences. A P value Ͻ 0.05 was considered statistically significant.
Results

Differences in Calculated Values for BE ecf
A comparison of the BE ecf values calculated with the various formulas is presented in Figure 1 . Under physiologic conditions (pH ϭ 7.4, Pco 2 ϭ 40 mm Hg), the maximal difference in the calculated BE ecf values was 0.64 mmol/L (Radiometer versus Ciba-Corning). The differences between the BE ecf values were enhanced during metabolic alkalosis and acidosis. The greatest difference during metabolic alkalosis in the observed range of values for BE ecf (Ϯ20 mmol/L) was 2.3 mmol/L; the formula used by IL 1620 and Nova STAT Profile Ultra yielded a BE ecf value of 20.0 mmol/L, whereas that used by the ABL 510 yielded a BE ecf value of 17.7 mmol/L (pH ϭ 7.619 and Pco 2 ϭ 40 mm Hg). The formulas differed even more in the case of extreme metabolic alkalosis; the calculated value for BE ecf was 34.6 mmol/L with the IL/Nova formulas and 30.0 mmol/L with the ABL 510 formula (pH ϭ 7.65 and Pco 2 ϭ 50 mm Hg). In the case of metabolic acidosis, the maximal difference in the calculated BE ecf value was 1.8 mmol/L, i.e., the formula used by Ciba-Corning 860 yielded a BE ecf of Ϫ20.0 mmol/L, whereas that used by the ABL 510 yielded a value of Ϫ18.2 mmol/L at pH ϭ 7.041 and Pco 2 ϭ 40 mm Hg.
Values for pH and Pco 2 within the usual reference range resulted in widely varying calculated BE ecf values: Ϫ6.7 mmol/L using the formula in Ciba-Corning 860 (pH ϭ 7.35, Pco 2 ϭ 35 mm Hg) and ϩ7.4 mmol/L using the formulas in IL and Nova instruments (pH ϭ 7.45, Pco 2 ϭ 45 mm Hg).
Reliability of Repeated Measurements
Of the 220 planned measurements of BE ecf , 199 were obtained in the 5 blood gas analyzers. Eight of the measurements were unsuccessful because the Nova Stat Profile Ultra reported error messages without results when analyzing blood samples tonometered with oxygen-free gas (contrary to the manual of this analyzer which specifies a range from 0.0 to 800.0 mm Hg for Po 2 ). The other 13 missing values were caused by various error messages, which were distributed among the analyzers.
On average, each sample was analyzed 5.9 times in each of the blood gas analyzers. The differences between the individual measurements and the mean of the repetitions are displayed in Figure 2 . The standard deviation of the differences for all analyzers was 3 Ϫ ϭ assumed "normal" concentration of bicarbonate that would result in a BE ecf of 0 mmol/L at "normal" pH ϭ 7.4; ␤ ecf ϭ a constant derived from several physiologic properties of human blood and extracellular fluid; HCO 3 Ϫ -factor ϭ factor used to calculate the bicarbonate concentration from the partial pressure of carbon dioxide and the pH of a blood sample.
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0.41 mmol/L. The maximal difference between an individual value for BE ecf and the mean value of all results measured by the same analyzer on the same sample was 3.19 mmol/L, which is nearly 8 times the standard deviation. This indicates that the errors do not follow a normal distribution (the KolmogorovSmirnov Goodness of Fit test confirms this with a nominal probability of P ϭ 0.0000 for the normal distribution). Thirty-three measurements showed differences of Ͼ1 mmol/L, 7 of Ͼ1.5 mmol/L, and 3 of Ͼ2 mmol/L. Assuming a normal distribution, this would be expected in 1.47% (15 of the 995 cases), 0.03% (0 cases), or 0.00006% (0 cases).
The pH results showed a standard deviation (means calculated separately for each analyzer and sample) of 0.0073 for the measurements on patients' blood and of 0.0051 for the other ones (significant with P Ͻ 0.0001 in Mann-Whitney test); the standard deviations of Pco 2 and BE ecf did not show significant differences between the patients' and healthy volunteers' blood.
Differences Between the Analyzers
Differences as large as 3.7 mmol/L were detected among the BE ecf values obtained using the various analyzers (mean results of 199 parallel measurements by Nova Stat Profile Ultra minus Ciba-Corning 860; Table 2 ). These differences were mainly attributed to systematic differences in the measured pH values (2.67 mmol/L [BE ecf ]) between these two analyzers, and to a lesser extent, to differences in calculation of BE ecf and determination of Pco 2 values. By using a unified algorithm for calculation [IFCC recommendation (4)], the maximal systematic differences of BE ecf could be reduced by 16%.
Differences Depending on the Type of Sample
The mean difference in BE ecf for the venous and arterial samples taken during surgery was 1 ; means of the two types of samples ϩ1.6 and Ϫ1.2 mmol/L). There was no statistically significant effect of the various gas mixtures on the decrease in BE ecf ; however, differences between the test gases of up to 5.6 mmol/L were found. Assuming normal distribution of the errors (cf. Discussion in main text), any single result could be expected to lie with a probability of about 95% within the interval formed by the mean of all measurements (the "true value" with all systematic errors) Ϯ twice these standard deviations. b Calculated using the mean values of pH and Pco 2 of all analyzers separately for each sample; only the formulas are specific to the analyzers (IL 1620 and Nova Stat Profile Ultra use the same formula).
c Calculated using the current IFCC formula (cf. Table 1 , last line), the mean values of Pco 2 of all analyzers separately for each sample, and the individual values for pH.
d Calculated using the current IFCC formula, the mean values of pH of all analyzers separately for each sample, and the individual values for Pco 2 . * All differences significant with P ϭ 0.0000 in Wilcoxon's matched-pairs signed rank test. † AVL C2-Nova SPU significant with P ϭ 0.0153 in Wilcoxon's matched-pairs signed rank test, all others with P ϭ 0.0000. ‡ All differences significant with P ϭ 0.0000 in Wilcoxon's matched-pairs signed rank test. § Calculated using the current IFCC formula, and the individual values for pH and Pco 2 . IL 1620 -C-C 860 significant with P ϭ 0.0021 in Wilcoxon's matched-pairs signed rank test, all others with P ϭ 0.0000.
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Storage of the venous samples in ice water for 6.5 h did not affect the BE ecf values (mean 0.05 mmol/L, P ϭ 0.473 in Mann-Whitney U-Test).
Discussion
BE ecf values are calculated from measurements of pH and Pco 2 obtained in a blood gas analyzer. These values are used clinically to identify metabolic acidosis and alkalosis, and as a basis for corrective therapy. This study showed significant variability in calculated BE ecf values using various analyzers, thus raising questions about the clinical usefulness of this index.
There is no consensus in the literature regarding the acceptable clinical range for BE ecf values, and which values should be of concern to the clinician. The reference intervals for BE ecf provided in the instrument manuals are typically in the range of Ϯ3 mmol/L, but the exact values vary considerably, and two of the manufacturers (IL, Nova Biomedical) provide no reference interval in their instrument manuals. The reference intervals offered for BE ecf are similar (or identical) to those offered for BE bl , which is considered redundant for clinical purposes (7) and no longer supported by the IFCC (4) . All of the instruments tested in this study offered values for both BE ecf and BE bl .
BE ecf is an estimate of how blood and the interstitial fluid that is in direct diffusional contact with the blood, respond to acid-base changes in vivo, whereas BE bl is a measure of base excess in an isolated blood sample. In the estimate for BE ecf , the volume of the interstitial fluid is considered to be approximately 2 times that of the blood (4). The sum of the blood and the interstitial fluid is an estimate of the "extracellular fluid." Within the physiologic range for pH, Pco 2 , and cHb, the calculated values for BE bl and BE ecf are nearly identical. However, in the case of hypercapnia, BE bl is considerably lower than BE ecf . For example, at Pco 2 ϭ 80 mm Hg, pH ϭ 7.2 and cHb ϭ 20 g/dL, the IL (IL 1620) and Nova Biomedical (Stat Profile Ultra) devices calculate a BE bl of ϩ2.6 mmol/L and a BE ecf of ϩ6.1 mmol/L. At Pco 2 ϭ 80 mm Hg, pH ϭ 7.2 and cHb ϭ 15 g/dL, the Roche device (AVL Compact 2) calculates a BE bl of Ϫ0.7 mmol/L and a BE ecf of ϩ2.7 mmol/L. Larger hemoglobin concentrations (only relevant for the calculation of BE bl ) further magnify this difference (BE bl ϭ Ϫ1.9 mmol/L at Pco 2 ϭ 80 mm Hg, pH ϭ 7.2, and cHb ϭ 20 g/dL).
Clinical decisions are often based on changes in BE ecf over time rather than on a single measurement. Studies on trauma patients have revealed that a decrease in BE ecf of approximately 3 mmol/L shows a good correlation to intraabdominal injury (8) , and is a predictor of mortality (9 -11) . In the multivariate logistic regression model developed by Rixen et al. (11) , a decrease of base excess by 3 mmol/L corresponds to a mortality odds ratio of 1.29, i.e., an approximately 30% increased risk to die. Smith et al. (12) demonstrated that a base excess value of less than Ϫ4 mmol/L predicted the risk of mortality with both sensitivity and specificity of approximately 70% for patients admitted to intensive care units. Unfortunately, these investigators did not provide the method of determination of base excess, e.g., whether BE ecf or BE bl was estimated, or the number and types of analyzers and formulas used.
Our findings indicating as much as a 3.7 mmol/L systematic difference for BE ecf values have obvious clinical relevance, because this difference corresponds to a 36% variation in mortality risk (11) . A patient with a nearly normal BE ecf of Ϫ0.4 mmol/L on one analyzer would be in the high-risk group according to the results of another analyzer. In the study in trauma patients alluded to above (8) , if the analyzer with a tendency toward the highest values was used on admission and that with a tendency toward the lowest values for the control measurements, most patients would be presumed to have a high risk for intraabdominal injury. If the sequence of the analyzers were reversed, a true decrease in BE ecf would likely never be discovered.
We found standard deviations between 0.24 and 0.48 mmol/L (see Table 2 ) for repeated measurements on the same sample in a given instrument. These findings imply that deviations of Ͼ2 mmol/L (approximately 4 standard deviations) must be expected less than once every 10,000 measurements, which would appear acceptable for clinical purposes. However, the observed deviations did not follow a "normal distribution," and large differences for parallel measurements were more frequent. This suggests that a repeat measurement may be in order if there is doubt about the accuracy of the first.
Our findings demonstrated that the variability of measurements within a given instrument was much less than that between instruments. Although the absence of a reference method ("gold standard") does not permit a determination of which of the tested instruments was more accurate, our findings suggest that at least some of them have errors in calibration.
To provide insight into the influence of time-related factors on analyzer reliability, we compared the present findings with those obtained three months earlier. This comparison demonstrated that the maximal difference in the value for pH increased with time (0.026 versus 0.037, respectively), resulting in a larger range for the values for BE ecf (1.0 versus 3.7 mmol/L). This may be related to deterioration of the buffer solutions used for calibration. The time-related alteration in the pH measurements was not detected despite the regular use of quality-control, buffer solutions, in accordance with the guidelines of the manufacturers. This is because the accepted intervals for pH and Pco 2 are wide, and capable themselves of producing differences in base excess of up to 8 mmol/L (13) .
The larger variability in the pH values of blood from patients versus that from volunteers is noteworthy, because it underscores the importance of not limiting reference measurements to healthy subjects; measurements from patients in various critical conditions would seem essential. This variability in pH values was most marked for cHb. The standard deviations (means calculated separately for each analyzer and sample) were 0.16 mmol/L ϭ 0.26 g/dL (ABL 510) and 0.21 mmol/L ϭ 0.34 g/dL for the samples from healthy volunteers; however, they were 0.86 mmol/L ϭ 1.37 g/dL, respectively, 0.64 mmol/L ϭ 1.03 g/dL for the samples from patients.
Another source of variation in the BE ecf values was the use of different equations for calculation. This is the result of two commissions (IFCC and National Committee for Clinical Laboratory Standards) suggesting different algorithms and of most manufacturers using others. The buffering properties of blood are very complex and affected by pathologic conditions, which makes them difficult to quantify (10, 13) . This limits the reliability of all the algorithms now in use. It is not possible to choose one algorithm over the others.
None of the currently used algorithms corrects for incomplete saturation of the hemoglobin with oxygen (Eq. 3); Roche has announced that it will add this feature to the AVL analyzers (2), but as yet has not done so. Thus, at this time, the values for BE ecf in fully saturated samples must be considered the most reliable. The results of our study suggest that, for both healthy persons and patients in stable condition undergoing surgery, venous and arterial samples yield nearly equivalent values for BE ecf , as long as the Haldane effect is quantified using the correction factor 0.03 mmol H ϩ per gram of hemoglobin (Eq. 3). This implies that the correction factor introduced by Zander (2) (0.02 mmol/g) for BE bl may not be sufficient for BE ecf . Correction for the Haldane effect is more important for estimates of BE ecf than for those of BE bl , because BE ecf is more affected by increases in Pco 2 , which occur concomitantly with decreases in oxygen saturation within the capillaries. Consequently, values for venous BE ecf are generally higher than the corresponding values for BE bl . During resuscitation and other critical conditions, venous BE ecf can be expected to decrease more than arterial BE ecf , particularly if sodium bicarbonate is administered (14 -17) . This arteriovenous difference in BE ecf values can serve as a valuable diagnostic tool in clinically critical situations. Thus, it is important that it not be obscured by lack of compensation for the Haldane effect.
Previous studies have suggested that the commercially available solutions may not have sufficient reliability for quality control of determinations of base excess (13, 18, 19) . Our findings suggest that untreated venous blood may provide a readily available and more reliable substitute in patients with normal acid-base balance, because the BE bl does not change (by definition) if Pco 2 changes during handling of the sample, unlike the base excess of these quality-control solutions, which have very different buffering properties. However, this approach would require compensation for the Haldane effect, because, otherwise, the rendered BE ecf values would be approximately ϩ2 mmol/L, and they would vary inversely with the So 2 of the venous blood sample.
The number of patients used in the present study was based on data from previous studies (2,13), and our clinical experience suggesting that this number would be necessary to encompass a variety of clinical conditions and a wide range of pH values. Variation in the acid-base status for healthy individuals was assumed to be small (as borne out in the present results), and thus only two normal volunteers were studied.
In conclusion, although values for base excess can be useful in detecting critical conditions in emergency and critical care medicine, they are derived values with significant sources of error and variability. It is important that the clinician appreciate these limitations of values for base excess, and do not rely on them exclusively to evaluate the metabolic status of the patient.
